Načítá se...
Selection of β‐Blocker in Patients With Cirrhosis and Acute Myocardial Infarction: A 13‐Year Nationwide Population‐Based Study in Asia
BACKGROUND: It is not clear whether β(1)‐selective or nonselective β‐blockers should be used in patients with cirrhosis and acute myocardial infarction. METHODS AND RESULTS: Medical records were retrieved from Taiwan NHIRD (National Health Insurance Research Database) during 2001‐2013. Patients were...
Uloženo v:
| Vydáno v: | J Am Heart Assoc |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6404872/ https://ncbi.nlm.nih.gov/pubmed/30371327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008982 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|